Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Review: Diagnosis of Helicobacter pylori infection.

Makristathis A, Hirschl AM, Mégraud F, Bessède E.

Helicobacter. 2019 Sep;24 Suppl 1:e12641. doi: 10.1111/hel.12641.

PMID:
31486244
2.

Prevalence and Outcome of Secondary Hemophagocytic Lymphohistiocytosis Among SIRS Patients: Results from a Prospective Cohort Study.

Gualdoni GA, Hofmann GA, Wohlfarth P, Winkler HM, Winkler S, Haslacher H, Thalhammer R, Makristathis A, Ratzinger F, Burgmann H.

J Clin Med. 2019 Apr 19;8(4). pii: E541. doi: 10.3390/jcm8040541.

3.

Combination of Nasal and Expanded Skin Swabs Enhances the Detection Rate of Staphylococcus aureus Colonization in Premature Infants.

Wisgrill L, Berger A, Waldhör T, Makristathis A, Assadian O, Rittenschober-Böhm J.

Pediatr Infect Dis J. 2019 Apr;38(4):422-423. doi: 10.1097/INF.0000000000002089.

PMID:
30882738
4.

Clinical characteristics of a large cohort of patients with positive culture of Fusobacterium necrophorum.

Klasinc R, Lupyr K, Zeller I, Paula H, Makristathis A, Tuchmann F, Wrba T, Assadian O, Presterl E.

GMS Infect Dis. 2018 Mar 7;6:Doc03. doi: 10.3205/id000038. eCollection 2018.

5.

Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing.

Spettel K, Barousch W, Makristathis A, Zeller I, Nehr M, Selitsch B, Lackner M, Rath PM, Steinmann J, Willinger B.

PLoS One. 2019 Jan 10;14(1):e0210397. doi: 10.1371/journal.pone.0210397. eCollection 2019.

6.

Re: Comment on "Incidence of risk factors for bloodstream infections in patients with major burns receiving intensive care: A retrospective single-center cohort study".

Fochtmann-Frana A, Freystätter C, Vorstandlechner V, Barth A, Bolliger M, Presterl E, Ihra G, Muschitz G, Mittlboeck M, Makristathis A, Rath T, Radtke C, Forstner C.

Burns. 2019 May;45(3):744-745. doi: 10.1016/j.burns.2018.12.008. Epub 2018 Dec 24. No abstract available.

PMID:
30591250
7.

Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis.

Kussmann M, Karer M, Obermueller M, Schmidt K, Barousch W, Moser D, Nehr M, Ramharter M, Poeppl W, Makristathis A, Winkler S, Thalhammer F, Burgmann H, Lagler H.

Emerg Microbes Infect. 2018 Dec 5;7(1):202. doi: 10.1038/s41426-018-0205-z.

8.

Substantial diagnostic impact of blood culture independent molecular methods in bloodstream infections: Superior performance of PCR/ESI-MS.

Makristathis A, Harrison N, Ratzinger F, Kussmann M, Selitsch B, Forstner C, Hirschl AM, Burgmann H.

Sci Rep. 2018 Oct 30;8(1):16024. doi: 10.1038/s41598-018-34298-7.

9.

Machine learning for fast identification of bacteraemia in SIRS patients treated on standard care wards: a cohort study.

Ratzinger F, Haslacher H, Perkmann T, Pinzan M, Anner P, Makristathis A, Burgmann H, Heinze G, Dorffner G.

Sci Rep. 2018 Aug 15;8(1):12233. doi: 10.1038/s41598-018-30236-9.

10.

Incidence of risk factors for bloodstream infections in patients with major burns receiving intensive care: A retrospective single-center cohort study.

Fochtmann-Frana A, Freystätter C, Vorstandlechner V, Barth A, Bolliger M, Presterl E, Ihra G, Muschitz G, Mittlboeck M, Makristathis A, Rath T, Radtke C, Forstner C.

Burns. 2018 Jun;44(4):784-792. doi: 10.1016/j.burns.2017.12.009. Epub 2018 Feb 1.

PMID:
29395408
11.

A multicenter prospective study on the diagnostic performance of a new liquid rapid urease test for the diagnosis of Helicobacter pylori infection.

Dolak W, Bilgilier C, Stadlmann A, Leiner J, Püspök A, Plieschnegger W, Siebert F, Wewalka F, Schöfl R, Huber-Schönauer U, Datz C, Biowski-Frotz S, Högenauer C, Schrutka-Kölbl C, Makristathis A, Schöniger-Hekele M, Steininger C; Austrian Helicobacter Pylori Study Group.

Gut Pathog. 2017 Dec 22;9:78. doi: 10.1186/s13099-017-0226-5. eCollection 2017.

12.

Detection of fungal pathogens by a new broad range real-time PCR assay targeting the fungal ITS2 region.

Zeller I, Schabereiter-Gurtner C, Mihalits V, Selitsch B, Barousch W, Hirschl AM, Makristathis A, Willinger B.

J Med Microbiol. 2017 Oct;66(10):1383-1392. doi: 10.1099/jmm.0.000575. Epub 2017 Sep 8.

PMID:
28884671
13.

Active Surveillance Cultures and Targeted Decolonization Are Associated with Reduced Methicillin-Susceptible Staphylococcus aureus Infections in VLBW Infants.

Wisgrill L, Zizka J, Unterasinger L, Rittenschober-Böhm J, Waldhör T, Makristathis A, Berger A.

Neonatology. 2017;112(3):267-273. doi: 10.1159/000477295. Epub 2017 Jul 14.

PMID:
28704818
14.

Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori.

Bilgilier C, Stadlmann A, Makristathis A, Thannesberger J, Kastner MT, Knoflach P, Steiner P, Schöniger-Hekele M, Högenauer C, Blesl A, Datz C, Huber-Schönauer U, Schöfl R, Wewalka F, Püspök A, Mitrovits N, Leiner J, Tilg H, Effenberger M, Moser M, Siebert F, Hinterberger I, Wurzer H, Stupnicki T, Watzinger N, Gombotz G, Hubmann R, Klimpel S, Biowski-Frotz S, Schrutka-Kölbl C, Graziadei I, Ludwiczek O, Kundi M, Hirschl AM, Steininger C; Austrian Helicobacter Study Group of the Austrian Society of Gastroenterology and Hepatology.

Clin Microbiol Infect. 2018 Mar;24(3):267-272. doi: 10.1016/j.cmi.2017.06.025. Epub 2017 Jun 29.

15.

Direct detection of Anaplasma phagocytophilum by polymerase chain reaction followed by electrospray ionization mass spectrometry from human blood.

Lagler H, Harrison N, Kussmann M, Obermüller M, Burgmann H, Makristathis A, Ramharter M.

Int J Infect Dis. 2017 Jul;60:61-63. doi: 10.1016/j.ijid.2017.05.006. Epub 2017 May 16.

16.

SeptiFast versus blood culture in clinical routine - A report on 3 years experience.

Korber F, Zeller I, Grünstäudl M, Willinger B, Apfalter P, Hirschl AM, Makristathis A.

Wien Klin Wochenschr. 2017 Jun;129(11-12):427-434. doi: 10.1007/s00508-017-1181-3. Epub 2017 Feb 27.

17.

Comprehensive evaluation of chemiluminescent immunoassays for the laboratory diagnosis of Clostridium difficile infection.

Makristathis A, Zeller I, Mitteregger D, Kundi M, Hirschl AM.

Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1253-1259. doi: 10.1007/s10096-017-2916-9. Epub 2017 Feb 8.

18.

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study.

Ratzinger F, Haslacher H, Stadlberger M, Schmidt RL, Obermüller M, Schmetterer KG, Perkmann T, Makristathis A, Marculescu R, Burgmann H.

Sci Rep. 2017 Jan 12;7:40646. doi: 10.1038/srep40646.

19.

Risk factors for Clostridium difficile infection in hemato-oncological patients: A case control study in 144 patients.

Fuereder T, Koni D, Gleiss A, Kundi M, Makristathis A, Zielinski C, Steininger C.

Sci Rep. 2016 Aug 11;6:31498. doi: 10.1038/srep31498.

20.

Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients.

Bilgilier C, Simonitsch-Klupp I, Kiesewetter B, Raderer M, Dolak W, Makristathis A, Steininger C.

Ann Hematol. 2016 Jun;95(7):1115-20. doi: 10.1007/s00277-016-2672-4. Epub 2016 Apr 19.

21.

Evaluation of the Septifast MGrade Test on Standard Care Wards--A Cohort Study.

Ratzinger F, Tsirkinidou I, Haslacher H, Perkmann T, Schmetterer KG, Mitteregger D, Makristathis A, Burgmann H.

PLoS One. 2016 Mar 17;11(3):e0151108. doi: 10.1371/journal.pone.0151108. eCollection 2016.

22.

Neither Single nor a Combination of Routine Laboratory Parameters can Discriminate between Gram-positive and Gram-negative Bacteremia.

Ratzinger F, Dedeyan M, Rammerstorfer M, Perkmann T, Burgmann H, Makristathis A, Dorffner G, Loetsch F, Blacky A, Ramharter M.

Sci Rep. 2015 Nov 2;5:16008. doi: 10.1038/srep16008.

23.

Activity of antimicrobial drugs against bacterial pathogens under mild hypothermic conditions.

Wallmüller C, Herold B, Sterz F, Makristathis A, Ramharter M.

Am J Emerg Med. 2015 Oct;33(10):1445-8. doi: 10.1016/j.ajem.2015.07.005. Epub 2015 Jul 4.

PMID:
26231525
24.

A risk prediction model for screening bacteremic patients: a cross sectional study.

Ratzinger F, Dedeyan M, Rammerstorfer M, Perkmann T, Burgmann H, Makristathis A, Dorffner G, Lötsch F, Blacky A, Ramharter M.

PLoS One. 2014 Sep 3;9(9):e106765. doi: 10.1371/journal.pone.0106765. eCollection 2014.

25.

Prevalence and risk factor assessment of Tropheryma whipplei in a rural community in Gabon: a community-based cross-sectional study.

Ramharter M, Harrison N, Bühler T, Herold B, Lagler H, Lötsch F, Mombo-Ngoma G, Müller C, Adegnika AA, Kremsner PG, Makristathis A.

Clin Microbiol Infect. 2014 Nov;20(11):1189-94. doi: 10.1111/1469-0691.12724.

26.

A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures.

Makristathis A, Riss S, Hirschl AM.

Clin Microbiol Infect. 2014 Oct;20(10):O760-3. doi: 10.1111/1469-0691.12561. Epub 2014 Feb 20.

27.

Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.

Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, Berry D.

Am J Gastroenterol. 2013 Oct;108(10):1620-30. doi: 10.1038/ajg.2013.257. Epub 2013 Sep 24.

PMID:
24060759
28.

Reversion and conversion of interferon-γ release assay results in HIV-1-infected individuals.

Aichelburg MC, Reiberger T, Breitenecker F, Mandorfer M, Makristathis A, Rieger A.

J Infect Dis. 2014 Mar 1;209(5):729-33. doi: 10.1093/infdis/jit418. Epub 2013 Aug 2.

PMID:
23911707
29.

Storage of bronchoalveolar lavage fluid and accuracy of microbiologic diagnostics in the ICU: a prospective observational study.

Kneidinger N, Warszawska J, Schenk P, Fuhrmann V, Bojic A, Hirschl A, Herkner H, Madl C, Makristathis A.

Crit Care. 2013 Jul 11;17(4):R135. doi: 10.1186/cc12814.

30.

Neutralization of antimicrobial substances in new BacT/Alert FA and FN Plus blood culture bottles.

Mitteregger D, Barousch W, Nehr M, Kundi M, Zeitlinger M, Makristathis A, Hirschl AM.

J Clin Microbiol. 2013 May;51(5):1534-40. doi: 10.1128/JCM.00103-13. Epub 2013 Mar 13.

31.

Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the liver: clinical, molecular, and microbiological aspects.

Kiesewetter B, Müllauer L, Streubel B, Agis H, Hirschl A, Makristathis A, Raderer M.

Ann Hematol. 2012 Nov;91(11):1817-8. doi: 10.1007/s00277-012-1459-5. Epub 2012 Apr 4. No abstract available.

PMID:
22476887
32.

Helicobacter pylori eradication rates in children upon susceptibility testing based on noninvasive stool polymerase chain reaction versus gastric tissue culture.

Vécsei A, Innerhofer A, Graf U, Binder C, Giczi H, Hammer K, Bruckdorfer A, Hirschl AM, Makristathis A.

J Pediatr Gastroenterol Nutr. 2011 Jul;53(1):65-70. doi: 10.1097/MPG.0b013e318210586d.

PMID:
21694538
33.

High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue.

Mitteregger D, Aberle SW, Makristathis A, Walochnik J, Brozek W, Marberger M, Kramer G.

Med Microbiol Immunol. 2012 Feb;201(1):113-6. doi: 10.1007/s00430-011-0205-2. Epub 2011 Jun 10.

PMID:
21660495
34.
35.

Interference of Mycoplasma infection in a gene expression study: it was the environment and not the gene.

Hoermann G, Spergser J, Einwallner E, Makristathis A, Perne A, Willinger B, Schwarzinger I.

Appl Environ Microbiol. 2010 Dec;76(23):7867-9. doi: 10.1128/AEM.01265-10. Epub 2010 Oct 1. Erratum in: Appl Environ Microbiol. 2011 Feb;77(3):1151.

36.

Time trends of Helicobacter pylori resistance to antibiotics in children living in Vienna, Austria.

Vécsei A, Kipet A, Innerhofer A, Graf U, Binder C, Gizci H, Hammer K, Bruckdorfer A, Huber WD, Hirschl AM, Makristathis A.

Helicobacter. 2010 Jun;15(3):214-20. doi: 10.1111/j.1523-5378.2010.00753.x. Erratum in: Helicobacter. 2010 Aug;15(4):313.

PMID:
20557363
37.

Stool polymerase chain reaction for Helicobacter pylori detection and clarithromycin susceptibility testing in children.

Vécsei A, Innerhofer A, Binder C, Gizci H, Hammer K, Bruckdorfer A, Riedl S, Gadner H, Hirschl AM, Makristathis A.

Clin Gastroenterol Hepatol. 2010 Mar;8(3):309-12. doi: 10.1016/j.cgh.2009.12.002. Epub 2009 Dec 28.

PMID:
20005978
38.

Data correction pre-processing for electronically stored blood culture results: implications on microbial spectrum and empiric antibiotic therapy.

Assadian O, Diab-Elschahawi M, Makristathis A, Blacky A, Koller W, Adlassnig KP.

BMC Med Inform Decis Mak. 2009 Jun 7;9:27. doi: 10.1186/1472-6947-9-27.

39.

Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals.

Aichelburg MC, Rieger A, Breitenecker F, Pfistershammer K, Tittes J, Eltz S, Aichelburg AC, Stingl G, Makristathis A, Kohrgruber N.

Clin Infect Dis. 2009 Apr 1;48(7):954-62. doi: 10.1086/597351.

PMID:
19245343
40.

A novel noninvasive genotyping method of Helicobacter pylori using stool specimens.

Puz S, Innerhofer A, Ramharter M, Haefner M, Hirschl AM, Kovách Z, Rotter M, Makristathis A.

Gastroenterology. 2008 Nov;135(5):1543-51. doi: 10.1053/j.gastro.2008.08.006. Epub 2008 Aug 19. Erratum in: Gastroenterology. 2009 May;136(5):1844.

PMID:
18835389
41.

Evaluation of a novel internally controlled real-time PCR assay targeting the 16S rRNA gene for confirmation of Neisseria gonorrhoeae infections.

Schabereiter-Gurtner C, Hufnagl P, Sonvilla G, Selitsch B, Rotter ML, Makristathis A, Hirschl AM.

Clin Microbiol Infect. 2008 May;14(5):480-6. doi: 10.1111/j.1469-0691.2008.01962.x. Epub 2008 Mar 4.

42.

Methods to detect Helicobacter pylori: from culture to molecular biology.

Hirschl AM, Makristathis A.

Helicobacter. 2007 Nov;12 Suppl 2:6-11. Review.

PMID:
17991170
43.

Evaluation of a protocol for molecular broad-range diagnosis of culture-negative bacterial infections in clinical routine diagnosis.

Schabereiter-Gurtner C, Nehr M, Apfalter P, Makristathis A, Rotter ML, Hirschl AM.

J Appl Microbiol. 2008 Apr;104(4):1228-37. Epub 2007 Nov 20.

44.

Detection and clarithromycin susceptibility testing of Helicobacter pylori in stool specimens by real-time PCR: how to get accurate test results.

Makristathis A, Hirschl AM, Rüssmann H, Koletzko S.

J Clin Microbiol. 2007 Aug;45(8):2756; author reply 2756-7. No abstract available.

45.

Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria.

Apfalter P, Assadian O, Daxböck F, Hirschl AM, Rotter ML, Makristathis A.

J Antimicrob Chemother. 2007 May;59(5):854-9. Epub 2007 Mar 8.

PMID:
17347178
46.

Non-invasive Helicobacter pylori diagnosis: stool or breath tests?

Hirschl AM, Makristathis A.

Dig Liver Dis. 2005 Oct;37(10):732-4. Review. No abstract available.

PMID:
15925556
47.

In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole.

Blacky A, Makristathis A, Apfalter P, Willinger B, Rotter ML, Hirschl AM.

Eur J Clin Microbiol Infect Dis. 2005 Apr;24(4):276-9.

PMID:
15902535
48.

Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens.

Schabereiter-Gurtner C, Hirschl AM, Dragosics B, Hufnagl P, Puz S, Kovách Z, Rotter M, Makristathis A.

J Clin Microbiol. 2004 Oct;42(10):4512-8.

49.

Exploration of anthropological specimens by GC-MS and chemometrics.

Varmuza K, Makristathis A, Schwarzmeier J, Seidler H, Mader RM.

Mass Spectrom Rev. 2005 May-Jun;24(3):427-52. Review.

PMID:
15389850
50.

Diagnosis of Helicobacter pylori infection.

Makristathis A, Hirschl AM, Lehours P, Mégraud F.

Helicobacter. 2004;9 Suppl 1:7-14. Review.

PMID:
15347300

Supplemental Content

Loading ...
Support Center